COMP <GO>
NXB vs TMO // ENTERPRISE SCALE & MARKET CAP
NextBoat Inc. Common Stcok (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NXB 3
— TMO 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $1.55 (+3.69%) • MKT CAP: $38.8M
market-cap
$38.8M
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NXB VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NXB | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 9.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.80% | 9.30% | +9.50 | NXB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.8x | 30.4x | -2.60 | NXB | /valuation <GO> |
| Free Cash Flow Yield | -3.28% | 2.40% | -5.68 | TMO | /fcf-yield <GO> |
| Operating Margin | 0.40% | 17.40% | -17.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | -1.60% | 15.10% | -16.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 21.10% | 3.90% | +17.20 | NXB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.18 | 4.50 | -1.32 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 26.2 | 62.9 | -36.72 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $38.8M | $262.22B | -$262.18B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NXB REV | TMO REV | NXB GROSS % | TMO GROSS % | NXB FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $119.9M | $44.56B | 9.6% | — | -$1.3M | $6.29B |
| FY 2024 | $99.0M | $42.88B | 8.9% | — | -$7.1M | $7.27B |
| FY 2023 | — | $42.86B | — | — | — | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NXB // BETA —
TMO // BETA 0.94